2025 fourth_quarter Filing
Q4Lobbying Activities
General pharmaceutical issues; Vaccine Injury Compensation Program (VICP); Pharmacy Benefit Manager (PBM) policy issues.
Monitor Section 232 investigations, new trade agreements and tariffs, pharmaceutical IP.
Drug pricing proposals. Pharmacy Benefit Manager reform proposals, clinical trial reforms, 340B. Vaccine safety and access issues, FDA reforms and changes, drug supply and shortage issues.